Featured Speakers

  • Eve CostopoulosVice President, Chief Ethics & Compliance Officer Eisai

  • Lauran S. D’AlessioVice President US Market Business Practices & Compliance, Merck

  • Justin A. DillonVice President, Chief Ethics & Compliance Officer Ipsen Biopharmaceuticals

  • Adriana MosailovDirector of Corporate Compliance & Business Practices Endo Pharmaceuticals

Share |
View all...

Prevent, detect and effectively respond to illegal interactions with government officials worldwide.

Download Brochure | Register Now

The outcome of the Pfizer settlement and latest investigations, such as the Teva Pharmaceuticals investigation, demonstrate the very real threat you face of violating the FCPA. Don’t become complacent. Make sure you are applying the most innovative measures and strategies to maintain a robust compliance program.

The increasing focus of enforcement agencies on the pharmaceutical industry creates a critical need to receive the most current advice on FCPA enforcement trends and industry best practices.

Hanson Wade’s Pharmaceutical Anti-Corruption Compliance meeting brings together senior compliance, legal, audit and logistics representatives to address the urgent compliance challenges faced by your high risk industry. The exclusive focus on the pharmaceutical industry means every piece of intelligence is tailored to address the specific challenges you face.

Attend this conference to protect yourself from enforcement action. You’ll leave armed with tangible intelligence and action points to establish a pro-active anti-corruption compliance program. 

Attend Pharmaceutical Anti-Corruption Compliance and:

  • Interpret new enforcement trends and understand what this means for you: Pfizer and the FCPA Professor analyse the latest settlements
  • Understand what is really meant by the FCPA “new era”: Identify where you are now most at risk and implement innovative solutions to mitigate this
  • Manage the legal complexities surrounding gifts and hospitality: Overcome the threats posed by this historical business model
  • Benchmark your compliance program with leading industry players: AstraZeneca, Boehringer Ingelheim Pharmaceuticals and Novartis reveal the steps they are taking to enhance their anti-corruption policies and procedures
  • Gain vital insights into effectively vetting your relationships with government officials and doctors worldwide
  • Develop global systems to support employee compliance through access to innovative training methods you can apply throughout your organization
  •  Understand how to deal with the worrying increase in shareholder and derivative lawsuits: Ensure you are employing stringent methods to ensure you don’t incur these substantial costs 
  • Reduce the risks associated with interaction between healthcare professionals and FMV in a global environment: The latest industry recommendations from Endo Pharmaceuticals

What's Next?

  1. Download the brochure to see more detail on how the program is shaping up

  2. Let us know if you’ve got material that you’re interested in presenting as there are opportunities to speak or sponsor

  3. Register now and secure your place early and take advantage of the early registration discounts